Literature DB >> 25731138

Irritable bowel syndrome: modern concepts and management options.

Gregory S Sayuk1, C Prakash Gyawali2.   

Abstract

Irritable bowel syndrome is the most common functional gastrointestinal disorder, manifesting as abdominal pain/discomfort and altered bowel function. Despite affecting as many as 20% of adults, a lack of understanding of etiopathogenesis and evaluation strategies results in diagnostic uncertainty, and in turn frustration of both the physician and the patient. This review summarizes the current literature on the diagnosis and management of irritable bowel syndrome, with attention to evidence-based approaches. A 4-step treatment strategy that has been used successfully in our tertiary referral practice is presented and should lead to successful therapeutic outcomes in the majority of patients with irritable bowel syndrome.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnosis; Irritable bowel; Pathophysiology; Treatment

Mesh:

Year:  2015        PMID: 25731138     DOI: 10.1016/j.amjmed.2015.01.036

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.

Authors:  Kyungsun Han; Jinghwa Wang; Jae-Gu Seo; Hojun Kim
Journal:  J Gastroenterol       Date:  2016-05-13       Impact factor: 7.527

2.  Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.

Authors:  Chao Du; Lijun Peng; Guanjun Kou; Peng Wang; Lin Lu; Yanqing Li
Journal:  Dig Dis Sci       Date:  2018-03-07       Impact factor: 3.199

3.  Insights on Disorders of Gut-Brain Interaction.

Authors:  Gregory S Sayuk
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-12

Review 4.  High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases.

Authors:  Mamie Gao; Allen Zhong; Neil Patel; Chiraag Alur; Dinesh Vyas
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

5.  Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Gregory S Sayuk; Ray Wolf; Lin Chang
Journal:  Am J Gastroenterol       Date:  2017-01-17       Impact factor: 10.864

6.  Aluminum Ingestion Promotes Colorectal Hypersensitivity in Rodents.

Authors:  Nicolas Esquerre; Lilian Basso; Caroline Dubuquoy; Madjid Djouina; Daniel Chappard; Catherine Blanpied; Pierre Desreumaux; Nathalie Vergnolle; Cécile Vignal; Mathilde Body-Malapel
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-09-20

7.  New Protocol for Production of Reduced-Gluten Wheat Bread and Pasta and Clinical Effect in Patients with Irritable Bowel Syndrome: A randomised, Double-Blind, Cross-Over Study.

Authors:  Maria Calasso; Ruggiero Francavilla; Fernanda Cristofori; Maria De Angelis; Marco Gobbetti
Journal:  Nutrients       Date:  2018-12-02       Impact factor: 5.717

Review 8.  Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.

Authors:  Duo-Chen Jin; Hai-Long Cao; Meng-Que Xu; Si-Nan Wang; Yu-Ming Wang; Fang Yan; Bang-Mao Wang
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

9.  Study of Antispasmodic and Antidiarrheal Activities of Tagetes lucida (Mexican Tarragon) in Experimental Models and Its Mechanism of Action.

Authors:  Rosa Ventura-Martinez; Guadalupe Esther Angeles-Lopez; Maria Eva Gonzalez-Trujano; Omar F Carrasco; Myrna Deciga-Campos
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-28       Impact factor: 2.629

10.  IBS Patients' Treatment Expectancy and Motivation Impacts Quality of the Therapeutic Alliance With Provider: Results of the IBS Outcome Study.

Authors:  Jeffrey M Lackner; Brian M Quigley; Christopher D Radziwon; Alison M Vargovich
Journal:  J Clin Gastroenterol       Date:  2021 May-Jun 01       Impact factor: 3.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.